![David Karlander](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Karlander
Corporate Officer/Principal en BIOCEPT, INC. .
Perfil
David Karlander is currently the Senior Vice President-Commercial Operations at Biocept, Inc. Previously, he worked as the Head-Clinical & Translational Sales at Mission Bio, Inc. He completed his undergraduate degree at Miami University and earned an MBA from Kellogg School of Management.
Cargos activos de David Karlander
Empresas | Cargo | Inicio |
---|---|---|
BIOCEPT, INC. | Corporate Officer/Principal | 03/08/2021 |
Antiguos cargos conocidos de David Karlander.
Empresas | Cargo | Fin |
---|---|---|
Mission Bio, Inc.
![]() Mission Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Formación de David Karlander.
Kellogg School of Management | Masters Business Admin |
Miami University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BIOCEPT, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Mission Bio, Inc.
![]() Mission Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Mission Bio, Inc. engages in the provision of tools for the study of cellular heterogeneity in human health and life science research. It develops research tools that allow high-throughput, single-cell nucleic acid characterization across a variety of research applications, including oncology and immunology. The company was founded by Charlie Silver, Adam Sciambi, Adam Abate, and Dennis Eastburn on June 29, 2011 and is headquartered in San Francisco, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- David Karlander